Form 13D/A NovaBay Pharmaceuticals For: 29 January
#NovaBay Pharmaceuticals #SEC Filing 13D/A #NBY stock #Beneficial ownership #Schedule 13D amendment #Biopharmaceutical news #Securities Exchange Act
📌 Key Takeaways
- NovaBay Pharmaceuticals filed a Form 13D/A with the SEC on January 29, representing a formal amendment to a prior ownership statement.
- The filing indicates a significant change in the beneficial ownership or voting power held by a major shareholder (one owning over 5% of the company).
- Such amendments are mandatory under federal securities laws to ensure market transparency regarding corporate control.
- The news is particularly relevant for investors tracking NovaBay’s stock (NBY) and its ongoing commercial strategy in the biopharmaceutical sector.
📖 Full Retelling
🐦 Character Reactions (Tweets)
Cyber-Stonk AnalystNovaBay just dropped a 13D/A. It’s either a masterstroke of corporate restructuring or the SEC's way of reminding us that watching billionaires swap 5% of a company is the closest thing we have to a spectator sport in the 2030s.
Gwen from GovernanceNothing says 'I’m rethinking my life choices' quite like a Schedule 13D amendment. Is it laboratory confidence or just high-stakes musical chairs with pharmaceutical equity? Either way, keep your eyes on the boardroom door.
Dr. Biotech IronyNovaBay is filing paperwork to disclose who is actually steering the ship. Ironically, the filing is so dense you’ll need some of their Avenova eye spray just to stop the stinging while reading it.
The Retail GhostSEC Form 13D/A: The legal way of saying 'Someone with way more money than you just changed their mind.' Welcome to the transparent capital structure, where we all get to watch the 5% club decide our fate.
Capitalism 2.0 BotAnalyzing NovaBay's shifting ownership. Is it a strategic merger or just a hedge fund manager liquidating their position to buy a private island? Compliance is beautiful, but the mystery is more profitable.
Sector 4 News MirrorNovaBay ownership shifts. In a world of anti-infectives and wound care, the most contagious thing remains the 'Significant Change in Intent' by a major shareholder. Wash your hands and update your portfolios.
💬 Character Dialogue
🏷️ Themes
Finance, Regulation, Pharmaceuticals
📚 Related People & Topics
Securities Exchange Act of 1934
1934 U.S. legislation establishing rules and regulatory bodies for financial markets
The Securities Exchange Act of 1934 (also called the Exchange Act, '34 Act, or 1934 Act) (Pub. L. 73–291, 48 Stat. 881, enacted June 6, 1934, codified at 15 U.S.C. § 78a et seq.) is a law governing the secondary trading of securities (stocks, bonds, and debentures) in the United States of America.
NovaBay Pharmaceuticals
Biopharmaceutical company
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
Beneficial ownership
Legal term
In domestic and international commercial law, a beneficial owner is a natural person (or persons) who ultimately owns or controls an interest in a legal entity or arrangement, such as a company, trust, or foundation. Legal owners (i.e. owners of record), commonly described as registered owners, may ...
🔗 Entity Intersection Graph
Connections for Securities Exchange Act of 1934:
- 🌐 SEC filing (7 shared articles)
- 🏢 Investor relations (4 shared articles)
- 🌐 Passive management (1 shared articles)
- 🌐 Agribusiness (1 shared articles)
- 🏢 Public company (1 shared articles)
- 🌐 Biotechnology (1 shared articles)
- 🌐 Portfolio management (1 shared articles)
- 🏢 Private equity (1 shared articles)
- 🏢 Vodafone (1 shared articles)
- 🏢 Corporate governance (1 shared articles)
- 🌐 Investment (1 shared articles)
📄 Original Source Content
{const a=e.bidRequestsCount||0;const t=Object.keys(n);for(const e of t){const o=n[e];if(a>=o[0]&&a e.bidder;if(e.que.push===Array.prototype.push&&(window.__pubxLoaded__||PUBX_FF_ALWAYS_ENABLED)){var d=document.createElement("link");d.rel="preload";d.href=a;d.as="fetch";d.crossOrigin=true;document.head.appendChild(d)}if(window.__pubxLoaded__){try{var u=localStorage.getItem("pubx:defaults");var i=JSON.parse(u);var _=i?i["data"]:o;window.__pubx__.pubxDefaultsAvailable=true;if(!_||_&&typeof _==="object"&&_.expiry Investing.com - Financial Markets Worldwide Open in App Popular Searches Please try another search Popular News More Gold prices soar back above $5,000/oz; Iran worries drive haven demand Software headwinds posed by AI unlikely to go away soon - Jefferies Analyst sees Tesla robotaxi revenue climbing to $250 billion by 2035 Software stocks slump; Alphabet to report; gold rises - what’s moving markets Get 50% Off Sign In Free Sign Up English (UK) English (India) English (Canada) English (Australia) English (South Africa) English (Philippines) English (Nigeria) Deutsch Español (España) Español (México) Français Italiano Nederlands Polski Português (Portugal) Português (Brasil) Русский Türkçe العربية Ελληνικά Svenska Suomi עברית 日本語 한국어 简体中文 繁體中文 Bahasa Indonesia Bahasa Melayu ไทย Tiếng Việt हिंदी Get 50% Off Sign In Free Sign Up Form 13D/A NovaBay Pharmaceuticals For: 29 January Filings Published 01/29/2026, 07:48 PM Form 13D/A NovaBay Pharmaceuticals For: 29 January View all comments (0) 0 Form 13D/A NovaBay Pharmaceuticals For: 29 January View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 49,605.90 +364.8 +0.74% US 500 6,912.70 -5.1 -0.07% Dow Jones 49,599.83 +358.84 +0.73% S&P 500 6,914.48 -3.31 -0.05% Nasdaq 23,119.25 -135.94 -0.59% S&P 500 VIX 18.19 +0.19 +1.06% Dollar Index 97.465 +0.164 +0.17% Crude Oil WTI Futures 63.44 +0.23 +0.36% Brent Oil Futures 67.64 +0.31 +0.46% Natu...